This review provides stepwise recommendations for diagnosing and managing moderate hypertriglyceridemia (200-500 mg/dL), emphasizing lifestyle adjustments and appropriate statin or nonstatin therapies.
Provides a practical, stepwise clinical approach to managing moderate hypertriglyceridemia to mitigate atherosclerotic cardiovascular disease risk.
Hypertriglyceridemia is a common lipid disorder encountered in clinical practice. Plasma triglycerides are a marker for the concentration of triglycerides carried in chylomicrons and very low-density lipoprotein particles. A fasting triglyceride level 1000 mg/dL. Because moderate hypertriglyceridemia does increase atherosclerotic cardiovascular disease risk, it is important to determine the underlying etiology to guide appropriate and timely management. This article provides stepwise recommendations on the diagnosis and management of moderate hypertriglyceridemia, based on 3 common scenarios encountered in clinical practice. Initial steps in management include evaluating for secondary contributors, especially diabetes mellitus. Based on patient characteristics, appropriate management decisions include lifestyle adjustments aimed at weight loss and decreasing alcohol consumption and use of statin and nonstatin therapies.
Savitha Subramanian (Sun,) conducted a review in Moderate Hypertriglyceridemia. This review provides stepwise recommendations for diagnosing and managing moderate hypertriglyceridemia (200-500 mg/dL), emphasizing lifestyle adjustments and appropriate statin or nonstatin therapies.